Overview

Robert Yarchoan, MD, Chief

The HIV and AIDS Malignancy Branch (HAMB) in the Center for Cancer Research of the National Cancer Institute conducts translational research on HIV infection and AIDS-related malignancies in children and adults. Investigators engage in basic laboratory research, preclinical studies, and clinical trials aimed at developing novel therapies for AIDS and AIDS-related malignancies and on understanding the effects of these therapies on disease pathogenesis. More information about the research effort in HAMB is available by clicking on HAMB Staff and Research.

The clinical research is directed toward treatment of HIV infection itself and cancers associated with AIDS, such as Kaposi's sarcoma and AIDS-associated non-Hodgkin's lymphoma. Clinical research trials are being conducted for both adults and pediatric patients with HIV infection or AIDS.

Information on HAMB adult and pediatric clinical trials is available by clicking on the relevant menu options to the left. Within each section, the protocol name is followed by a brief description. You can click on the protocol name to get more detailed information about the protocol.

If one of the protocols interests you, e-mail or call the indicated contact person for the protocol at the number listed.